We reported the news this past week that the FDA will require label changes to guide prescribers on gradual, individualized tapering of opioids. The Agency…
The FDA’s safety announcement this week that says it has identified harm reported from sudden discontinuation of opioid pain medicines and is requiring label changes…
Living with conditions that cause an incredible amount of pain, daily, was never part of how most patients envisioned their future. Coming to terms with…
Chronic Pain Patients are grateful that Terri Lewis Ph.D. is one of their most eloquent spokespersons. She shared with the National Pain Report what she…
(The April 1 deadline to provide comment on the recommendations of the U.S. Pain Management Best Practices Inter-Agency Task Force is drawing near. Angelika Byczkowski…